Bilateral blindness and lumbosacral myelopathy associated with high-dose carmustine and cisplatin therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11020424.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To report the early ocular pathologic findings associated with high-dose carmustine and cisplatin therapy. A patient with metastatic breast carcinoma developed an acute onset of branch retinal artery occlusion, bilateral blindness, and a myelopathy involving the lower extremities after high-dose chemotherapy and bone marrow transplant. Histopathologic examination of the eye and optic nerves at autopsy disclosed nerve fiber layer infarction secondary to right inferior temporal retinal artery thrombosis. Patchy necrosis of both optic nerves, medulla oblongata, and spinal cord was associated with focal small-vessel thrombosis. The syndrome of retinal vascular occlusion, optic neuropathy, and myelopathy is associated with the high-dose chemotherapeutic agents carmustine and cisplatin. The distribution of necrosis suggests an ischemic event rather than direct neurotoxic effects.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Blindness
- Carmustine
- Cisplatin
- Retinal Artery Occlusion
- Spinal Cord Diseases